CTKB - Cytek Biosciences, Inc.
Cytek Biosciences, Inc. , a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; and aurora cell sorter system, which leverages full spectrum profiling technology to further broaden potential applications across cell analysis.
As of May 15, 2026: spot at $3.45, ATM IV 24.2%, max pain $2.50, net GEX $26.
- Sector
- Healthcare
- Industry
- Medical - Devices
- Market Cap
- $475.2M
- Beta
- 1.23
- 52-Week Range
- 2.37-6.18
- CEO
- Wenbin Jiang
- Employees
- 663
- IPO Date
- Jul 23, 2021
- Exchange
- NASDAQ
What CTKB Looks Like to Options Traders Today
IV rank of 1.4% is subdued relative to the 1-year history, conditions that typically favor premium-buying or long-volatility structures (debit spreads, calendar spreads, long straddles); positive net gamma exposure ($26) means dealers hedge against trend, damping realized volatility and biasing price toward heavy-OI strikes.
What This Page Covers
The CTKB overview links into per-metric analysis views: max pain, gamma exposure, volatility skew, expected move, options chain, open interest history, and aggregate Greeks. Microstructure data is available on short interest, short volume, fail-to-deliver, and market structure. Corporate data is on fundamentals, earnings, analyst ratings, and insider trading.
Frequently asked CTKB overview questions
- What is CTKB?
- CTKB is the ticker symbol for Cytek Biosciences, Inc., a listed security. Cytek Biosciences, Inc. , a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. Listed on NASDAQ. CTKB is the equity ticker shown on this page; equity options traders use the security for directional, volatility, and income strategies via the listed options chain.
- What does the CTKB options snapshot look like today?
- As of May 15, 2026, the CTKB options snapshot shows spot at $3.45, ATM IV 24.2%, IV rank 1.4%, max pain $2.50, net GEX $26, expected move 6.94%. The full options chain, Greeks by strike and expiration, per-strike open-interest distribution, dealer gamma and delta exposure, and the volatility skew surface are linked from this overview page. Each per-metric route refreshes once per trading session and reflects the most recent close-of-business listed-options state.
- What are CTKB's key statistics?
- Cytek Biosciences, Inc. (CTKB) carries a market capitalization of $475.2M, beta of 1.23 relative to the broader market, 52-week range of 2.37-6.18. Full income statement, balance sheet, cash flow, and TTM ratio history is on the per-ticker fundamentals page; daily price history and 52-week levels are accessible from the same view. These structural inputs frame how the options market prices implied volatility around earnings windows and capital events.
- What sector or industry does CTKB belong to?
- Cytek Biosciences, Inc. operates in the Healthcare sector, in the Medical - Devices industry. Sector classification affects how the ticker correlates with sector ETFs, how it reacts to macro factors like rate moves and commodity prices, and how its options pricing compares to sector peers. Compare CTKB's implied volatility and skew against sector benchmarks to gauge whether the options market is pricing single-name or systemic risk relative to the broader peer group.
- How current is the CTKB data on this page?
- The options snapshot above is dated May 15, 2026 and refreshes once per session, with all per-strike Greeks and exposure aggregates recomputed at the daily close. Company-profile fields (sector, industry, market cap, P/E, IPO date) refresh from the vendor feed nightly. Financials and earnings refresh as 10-K and 10-Q filings are parsed (typically within several business days of the actual report). FINRA microstructure data refreshes on the source's cadence (daily for short volume, bi-monthly for short interest, weekly for the OTC volume file, twice-monthly for SEC FTD).